Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map.
Casas-Maldonado F, Álvarez-Gutiérrez FJ, Blanco-Aparicio M, Domingo-Ribas C, Cisneros-Serrano C, Soto-Campos G, Román-Bernal B, González-Barcala FJ. Casas-Maldonado F, et al. Among authors: domingo ribas c. J Asthma. 2022 Oct;59(10):1997-2007. doi: 10.1080/02770903.2021.1978483. Epub 2021 Sep 17. J Asthma. 2022. PMID: 34503370
What's New in the 2022 Consensus for Severe Asthma in Adults.
Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiña-Tordera M, Soto-Campos G. Alvarez-Gutiérrez FJ, et al. Among authors: domingo ribas c. Arch Bronconeumol. 2023 Mar;59(3):190-192. doi: 10.1016/j.arbres.2022.09.012. Epub 2022 Sep 28. Arch Bronconeumol. 2023. PMID: 36243640 English, Spanish. No abstract available.
Mepolizumab treatment in patients with severe eosinophilic asthma.
Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P; MENSA Investigators. Ortega HG, et al. N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Free article. Clinical Trial.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Is asthma control more than just an absence of symptoms? An expert consensus statement.
Canonica GW, Spanevello A, de Llano LP, Domingo Ribas C, Blakey JD, Garcia G, Inoue H, Dalcolmo M, Yang D, Mokashi S, Kurne A, Butta AK. Canonica GW, et al. Among authors: domingo ribas c. Respir Med. 2022 Oct;202:106942. doi: 10.1016/j.rmed.2022.106942. Epub 2022 Aug 4. Respir Med. 2022. PMID: 36096072 Free article. Review.
Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma.
Katsaounou P, Odemyr M, Spranger O, Hyland ME, Kroegel C, Conde LG, Gore R, Menzella F, Domingo Ribas C, Morais-Almeida M, Gasser M, Kasujee I. Katsaounou P, et al. Among authors: domingo ribas c. ERJ Open Res. 2018 Dec 21;4(4):00076-2018. doi: 10.1183/23120541.00076-2018. eCollection 2018 Oct. ERJ Open Res. 2018. PMID: 30588481 Free PMC article.
23 results